NewsZurich Seeks Cannabis Club Volunteers And Swiss Business To...

Zurich Seeks Cannabis Club Volunteers And Swiss Business To Support Its Adult-Use Trial


SWITZERLAND’S largest city Zurich has unveiled details of its adult-use recreational trial which is set to begin in Autumn next year.

Entitled ‘Züri Can – Cannabis with Responsibility’ the three-and-a-half-year study forms part of the country-wide, adult-use cannabis trial which also includes the cities of Basel, Bern, Lucerne and Geneva.

Switzerland’s adult-use cannabis pilot is designed to help shape any future cannabis legislation at the federal level.

In a joint press release with the Psychiatric University Clinic Zurich and the Zurich Pharmacy Network, the City of Zurich says ‘the study participants will be able to obtain their study cannabis from pharmacies and social clubs’. 

Promote Public Health

It goes on to say: “The aim of the Zurich study is to provide relevant knowledge on the best possible use of cannabis. The study is intended to promote public health, maintain public safety and support the protection of minors.”

Zurich says its trial will examine the optimum ways regulated cannabis can be purchased whilst monitoring its effects on the health and consumption behaviour of the consumer. 

The press release calls for ‘interested pharmacies and interested parties who would like to found and operate a social club’ to get in touch.

It adds: “At all purchase points, value is placed on personal and health-promoting advice and on responding to individual needs. The aim is always to keep the health risks for consumers as low as possible.”

Guidelines For Businesses 

The launch of the pilot project follows changes to the country’s Narcotics Act in May 2021, which mandated pilot tests for regulated cannabis sales. 

Cannabis producers providing the study will need a production permit issued by the Federal Office of Public Health. 

The release adds: “Only cannabis meeting high quality standards will be distributed, with priority given to organic quality cannabis and locally produced.”

Stevens Senn, CEO, of Pure Holding AG, one of Switzerland’s leading cannabis genome experts, cultivators, processors and distributors welcomed the developments. 

Speaking to BusinessCann he said: “The current situation is unsatisfactory: consumption has been stagnating at a high level for years and there is a considerable black market with corresponding risks for consumers. 

“A regulated market ensures a clear increase in product safety and quality. Therefore, the successful implementation of the pilot projects and the associated development of a solid data basis on the effects of a regulated cannabis market on individual and public health, consumer behaviour, protection of minors, and public order and safety is enormously important to us.”

Whilst providing opportunities for the business he believes Pure Holding’s extensive experience will benefit the sector as a whole. He continued: “As the market leader of the Swiss cannabis industry, we consider it our responsibility to support politics in this new area. 

“Through our many years of experience and our extensive field trials from 2020, we have been able to gain valuable insights with THC and we can therefore provide expertise as advisors.”

He added: “We are proud of Switzerland and its politics for taking this important and progressive approach. Switzerland is becoming a pioneer. Therefore it is enormously important to exploit the potential of this long-forbidden plant.”

During the study different cannabis products will be offered, each with a different THC to CBD content, and the participants will be monitored on a regular basis to gauge their views on its progress.

Possession of less than 10 grams is already permitted in Zurich.

Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.


  1. Great, we are moving forward. Sad that the study allows 5000 participants but the organizers want only 1500 paticipants for the Zurich pilot. (Basel 400… etc.) Not a whole lot.

Comments are closed.

Latest news

German Prohibitionists Lobby EU, German Medical Cannabis Re-Think, High Court Blow For Irish CBD, Hemp Batteries In Electric Vehicles?

GERMAN opponents of its adult-use cannabis programme are taking their fight to Brussels in a bid to scupper the...

Akanda Pulls Out Of Lesotho Amid Ongoing Legal Battle, Bruce Linton Joins SynBiotic, & Ananda Completes Acquisition

Akanda The NASDAQ-listed international medical cannabis operator announced last week that it will abandon its operations in Lesotho following...

Concerns Grow As Cannabis Sceptic Appointed To Lead Malta’s Adult-Use Reform

ALMOST one year since passing legislation fears are growing the Maltese Government is set to undermine its commitment to...

Brains Bio Receives NSF’s First CBD Certification For EU GMP CBD API

PRESS RELEASE BRAINS Bioceutical Corp ("Brains Bio" or the "Company"), a global leader in EU GMP grade Cannabidiol (CBD) has...

Amsterdam Cannabis Expo 2022 Latest Scam To Target Industry

AN upcoming European cannabis conference, at which 10,000 cannabis companies were purportedly due to visit, is thought to be...

Juicy Fields Scam May Have Been Small Part Of A Much Larger Criminal Enterprise Says Lawyer As He Prepares To Make Evidence Public

JUICY Fields has already been called the biggest scam in Europe for ‘many, many years’, and its impact on...

Must read

Akanda Pulls Out Of Lesotho Amid Ongoing Legal Battle, Bruce Linton Joins SynBiotic, & Ananda Completes Acquisition

Akanda The NASDAQ-listed international medical cannabis operator announced last...

You might also likeRELATED
Recommended to you